VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects

Absence of dystrophin makes skeletal muscle more susceptible to injury, resulting in breaches of the plasma membrane and chronic inflammation in Duchenne muscular dystrophy (DMD). Current management by glucocorticoids has unclear molecular benefits and harsh side effects. It is uncertain whether the...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Heier, Christopher R, Damsker, Jesse M, Yu, Qing, Dillingham, Blythe C, Huynh, Tony, Van der Meulen, Jack H, Sali, Arpana, Miller, Brittany K, Phadke, Aditi, Scheffer, Luana, Quinn, James, Tatem, Kathleen, Jordan, Sarah, Dadgar, Sherry, Rodriguez, Olga C, Albanese, Chris, Calhoun, Michael, Gordish-Dressman, Heather, Jaiswal, Jyoti K, Connor, Edward M, McCall, John M, Hoffman, Eric P, Reeves, Erica K M, Nagaraju, Kanneboyina
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2013
Предметы:
Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3799580/
https://ncbi.nlm.nih.gov/pubmed/24014378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201302621
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы